Although many studies have revealed that there is an association of plasma MMP‐9 levels with HT risk (Castellanos et al., 2007; Jha et al., 2014; del Zoppo et al., 2012), the effect of MMP‐9 SNPs on HT susceptibility is not clear. This evidence concerns the gene MMP9 and hematocrit.